Advertisement

Topics

Abemaciclib Shows Activity for HR-Positive Breast Cancer Brain Mets

20:00 EDT 29 Jun 2017 | Cancer Networks

This video examines an early trial studying abemaciclib for the treatment of brain metastases in patients with hormone receptor–positive, HER2-negative breast cancer.

Original Article: Abemaciclib Shows Activity for HR-Positive Breast Cancer Brain Mets

NEXT ARTICLE

More From BioPortfolio on "Abemaciclib Shows Activity for HR-Positive Breast Cancer Brain Mets"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Endocrine Disorders
Endocrine disorders are grouped into two categories: hormone imbalance - when a gland produces too much or too little of an endocrine hormone development of lesions (such as nodules or tumors) in the endocrine system, which may or may not affect...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...